Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Covalon Technologies Ltd.: Press Release.


MISSISSAUGA, Ontario For the First Nation, see .

Mississauga (pronounced: [ˌmɪsɪˈsɑgə] listen  
 -- Covalon Technologies Ltd. (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
 VENTURE:COV COV Composés Organiques Volatiles (French)
COV Compuestos Orgánicos Volátiles (Spanish: Volatile Organic Compounds)
COV Coefficient of Variation
COV City of Villians (game) 
) has entered into an 18 month financial advisory agreement with Y&R Investment Capital Inc. Y&R will be paid $5,000 per month and granted 350,000 options with varying vesting dates. The options are exercisable at $0.40 per share and expire on the second anniversary of the date of grant.

The TSX Venture Exchange TSX Venture Exchange

Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors.
 has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this release.

Covalon Technologies Inc. (TSX VENTURE:COV)
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 9, 2005
Words:115
Previous Article:High River Gold Wins Auction For Russia's Novophirsovskoye Ore Field.
Next Article:Equinix Reports Fourth Quarter and Year-End 2004 Results.



Related Articles
Covalon Signs U.S. Distribution Agreement with Hartmann-Conco.
Covalon Signs U.S. Licensing Letter Of Intent For Its Anitmicrobial Coating Technology.
Covalon Successfully Cultures Cells Using Its Collagen-Based Scaffold For Tissue Regeneration.
Covalon Recieves FDA Approval For Its Collagen Scaffold For Wound Dressing Applications.
Covalon Receives FDA Approval For Its Antimicrobial Silver Collagen Wound Dressing.
Covalon Launches Collagen Wound Dressings.
Covalon and Medline Industries apply for FDA approval for Covalon's silver ion antimicrobial coating.
Covalon Recommended for ISO 13485:2003 Certification.
Jacques Lemmetti Appointed Chairman of the Board at Covalon.
Covalon Receives European Patent For Drug Delivery Via Therapeutic Hydrogels.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles